메뉴 건너뛰기




Volumn 9, Issue 22, 2016, Pages 2343-2352

Cost-Effectiveness of Endovascular Femoropopliteal Intervention Using Drug-Coated Balloons Versus Standard Percutaneous Transluminal Angioplasty: Results From the IN.PACT SFA II Trial

Author keywords

angioplasty; cost effectiveness; drug coated balloon; femoropopliteal artery; peripheral arterial disease

Indexed keywords

AGED; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG COATED BALLOON; ENDOVASCULAR SURGERY; FEMALE; FEMOROPOPLITEAL BYPASS; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITALIZATION COST; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY BALLOON; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL; ADVERSE EFFECTS; CLINICAL TRIAL; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; COST CONTROL; DECISION SUPPORT SYSTEM; DEVICES; DIAGNOSTIC IMAGING; DRUG COST; ECONOMIC MODEL; ECONOMICS; EQUIPMENT DESIGN; FEMORAL ARTERY; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PERIPHERAL ARTERIAL DISEASE; POPLITEAL ARTERY; STENOSIS, OCCLUSION AND OBSTRUCTION; TIME FACTOR; TREATMENT OUTCOME; UNITED STATES; VASCULAR ACCESS DEVICE;

EID: 84997079068     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2016.08.036     Document Type: Article
Times cited : (52)

References (21)
  • 1
    • 0035206979 scopus 로고    scopus 로고
    • PAD awareness, risk, and treatment: new resources for survival—the USA PARTNERS program
    • 1 Hirsch, A.T., Hiatt, W.R., PAD awareness, risk, and treatment: new resources for survival—the USA PARTNERS program. Vasc Med 6 (2001), 9–12.
    • (2001) Vasc Med , vol.6 , pp. 9-12
    • Hirsch, A.T.1    Hiatt, W.R.2
  • 2
    • 0037471546 scopus 로고    scopus 로고
    • Critical issues in peripheral arterial disease detection and management: a call to action
    • 2 Belch, J.J., Topol, E.J., Agnelli, G., et al. Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med 163 (2003), 884–892.
    • (2003) Arch Intern Med , vol.163 , pp. 884-892
    • Belch, J.J.1    Topol, E.J.2    Agnelli, G.3
  • 3
    • 68349161985 scopus 로고    scopus 로고
    • One-year costs in patients with a history of or at risk for atherothrombosis in the United States
    • 3 Mahoney, E.M., Wang, K., Cohen, D.J., et al. One-year costs in patients with a history of or at risk for atherothrombosis in the United States. Circ Cardiovasc Qual Outcomes 1 (2008), 38–45.
    • (2008) Circ Cardiovasc Qual Outcomes , vol.1 , pp. 38-45
    • Mahoney, E.M.1    Wang, K.2    Cohen, D.J.3
  • 4
    • 33846497950 scopus 로고    scopus 로고
    • Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
    • 4 Norgren, L., Hiatt, W.R., Dormandy, J.A., Nehler, M.R., Harris, K.A., Fowkes, F.G., Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 45:Suppl S (2007), S5–S67.
    • (2007) J Vasc Surg , vol.45 , pp. S5-S67
    • Norgren, L.1    Hiatt, W.R.2    Dormandy, J.A.3    Nehler, M.R.4    Harris, K.A.5    Fowkes, F.G.6
  • 5
    • 78650238256 scopus 로고    scopus 로고
    • Vascular hospitalization rates and costs in patients with peripheral artery disease in the United States
    • 5 Mahoney, E.M., Wang, K., Keo, H.H., et al. Vascular hospitalization rates and costs in patients with peripheral artery disease in the United States. Circ Cardiovasc Qual Outcomes 3 (2010), 642–651.
    • (2010) Circ Cardiovasc Qual Outcomes , vol.3 , pp. 642-651
    • Mahoney, E.M.1    Wang, K.2    Keo, H.H.3
  • 6
    • 84055172778 scopus 로고    scopus 로고
    • The treatment of femoropopliteal in-stent restenosis: back to the future
    • 6 Laird, J.R., Yeo, K.K., The treatment of femoropopliteal in-stent restenosis: back to the future. J Am Coll Cardiol 59 (2012), 24–25.
    • (2012) J Am Coll Cardiol , vol.59 , pp. 24-25
    • Laird, J.R.1    Yeo, K.K.2
  • 7
    • 11844296114 scopus 로고    scopus 로고
    • Prevalence and clinical impact of stent fractures after femoropopliteal stenting
    • 7 Scheinert, D., Scheinert, S., Sax, J., et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol 45 (2005), 312–315.
    • (2005) J Am Coll Cardiol , vol.45 , pp. 312-315
    • Scheinert, D.1    Scheinert, S.2    Sax, J.3
  • 8
    • 84923684095 scopus 로고    scopus 로고
    • Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial
    • 8 Tepe, G., Laird, J., Schneider, P., et al. Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial. Circulation 131 (2015), 495–502.
    • (2015) Circulation , vol.131 , pp. 495-502
    • Tepe, G.1    Laird, J.2    Schneider, P.3
  • 9
    • 84958961875 scopus 로고    scopus 로고
    • Sustained durability of treatment effect using a drug-coated balloon for femoropopliteal lesions: 24-month results of IN.PACT SFA
    • 9 Laird, J.R., Schneider, P.A., Tepe, G., et al. Sustained durability of treatment effect using a drug-coated balloon for femoropopliteal lesions: 24-month results of IN.PACT SFA. J Am Coll Cardiol 66 (2015), 2329–2338.
    • (2015) J Am Coll Cardiol , vol.66 , pp. 2329-2338
    • Laird, J.R.1    Schneider, P.A.2    Tepe, G.3
  • 10
    • 84936746214 scopus 로고    scopus 로고
    • Trial of a paclitaxel-coated balloon for femoropopliteal artery disease
    • 10 Rosenfield, K., Jaff, M.R., White, C.J., et al. Trial of a paclitaxel-coated balloon for femoropopliteal artery disease. N Engl J Med 373 (2015), 145–153.
    • (2015) N Engl J Med , vol.373 , pp. 145-153
    • Rosenfield, K.1    Jaff, M.R.2    White, C.J.3
  • 11
    • 84880119627 scopus 로고    scopus 로고
    • Cost-effectiveness analysis of enhancements to angioplasty for infrainguinal arterial disease
    • 11 Kearns, B.C., Michaels, J.A., Stevenson, M.D., Thomas, S.M., Cost-effectiveness analysis of enhancements to angioplasty for infrainguinal arterial disease. Br J Surg 100 (2013), 1180–1188.
    • (2013) Br J Surg , vol.100 , pp. 1180-1188
    • Kearns, B.C.1    Michaels, J.A.2    Stevenson, M.D.3    Thomas, S.M.4
  • 12
    • 84908196442 scopus 로고    scopus 로고
    • Economic analysis of endovascular interventions for femoropopliteal arterial disease: a systematic review and budget impact model for the United States and Germany
    • 12 Pietzsch, J.B., Geisler, B.P., Garner, A.M., Zeller, T., Jaff, M.R., Economic analysis of endovascular interventions for femoropopliteal arterial disease: a systematic review and budget impact model for the United States and Germany. Catheter Cardiovasc Interv 84 (2014), 546–554.
    • (2014) Catheter Cardiovasc Interv , vol.84 , pp. 546-554
    • Pietzsch, J.B.1    Geisler, B.P.2    Garner, A.M.3    Zeller, T.4    Jaff, M.R.5
  • 13
    • 14844319324 scopus 로고    scopus 로고
    • US valuation of the EQ-5D health states: development and testing of the D1 valuation model
    • 13 Shaw, J.W., Johnson, J.A., Coons, S.J., US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care 43 (2005), 203–220.
    • (2005) Med Care , vol.43 , pp. 203-220
    • Shaw, J.W.1    Johnson, J.A.2    Coons, S.J.3
  • 14
    • 0028790206 scopus 로고
    • In-hospital and one-year economic outcomes after coronary stenting or balloon angioplasty. Results from a randomized clinical trial
    • 14 Cohen, D.J., Krumholz, H.M., Sukin, C.A., et al. In-hospital and one-year economic outcomes after coronary stenting or balloon angioplasty. Results from a randomized clinical trial. Circulation 92 (1995), 2480–2487.
    • (1995) Circulation , vol.92 , pp. 2480-2487
    • Cohen, D.J.1    Krumholz, H.M.2    Sukin, C.A.3
  • 15
    • 3543064732 scopus 로고    scopus 로고
    • Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial
    • 15 Cohen, D.J., Bakhai, A., Shi, C., et al. Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial. Circulation 110 (2004), 508–514.
    • (2004) Circulation , vol.110 , pp. 508-514
    • Cohen, D.J.1    Bakhai, A.2    Shi, C.3
  • 16
    • 0037348974 scopus 로고    scopus 로고
    • Comparison of analytic approaches for the economic evaluation of new technologies alongside multicenter clinical trials
    • 16 Taira, D.A., Seto, T.B., Siegrist, R., Cosgrove, R., Berezin, R., Cohen, D.J., Comparison of analytic approaches for the economic evaluation of new technologies alongside multicenter clinical trials. Am Heart J 145 (2003), 452–458.
    • (2003) Am Heart J , vol.145 , pp. 452-458
    • Taira, D.A.1    Seto, T.B.2    Siegrist, R.3    Cosgrove, R.4    Berezin, R.5    Cohen, D.J.6
  • 17
    • 84892987217 scopus 로고    scopus 로고
    • The LEVANT I (Lutonix Paclitaxel-Coated Balloon for the Prevention of Femoropopliteal Restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty
    • 17 Scheinert, D., Duda, S., Zeller, T., et al. The LEVANT I (Lutonix Paclitaxel-Coated Balloon for the Prevention of Femoropopliteal Restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty. J Am Coll Cardiol Intv 7 (2014), 10–19.
    • (2014) J Am Coll Cardiol Intv , vol.7 , pp. 10-19
    • Scheinert, D.1    Duda, S.2    Zeller, T.3
  • 18
    • 84899512831 scopus 로고    scopus 로고
    • Mortality rates and mortality predictors in patients with symptomatic peripheral artery disease stratified according to age and diabetes
    • 18 Mueller, T., Hinterreiter, F., Luft, C., Poelz, W., Haltmayer, M., Dieplinger, B., Mortality rates and mortality predictors in patients with symptomatic peripheral artery disease stratified according to age and diabetes. J Vasc Surg 59 (2014), 1291–1299.
    • (2014) J Vasc Surg , vol.59 , pp. 1291-1299
    • Mueller, T.1    Hinterreiter, F.2    Luft, C.3    Poelz, W.4    Haltmayer, M.5    Dieplinger, B.6
  • 19
    • 0031900689 scopus 로고    scopus 로고
    • Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis
    • 19 Stinnett, A.A., Mullahy, J., Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis. Med Decis Making 18 (1998), S68–S80.
    • (1998) Med Decis Making , vol.18 , pp. S68-S80
    • Stinnett, A.A.1    Mullahy, J.2
  • 20
    • 84901630147 scopus 로고    scopus 로고
    • ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines
    • 20 Anderson, J.L., Heidenreich, P.A., Barnett, P.G., et al. ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines. J Am Coll Cardiol 63 (2014), 2304–2322.
    • (2014) J Am Coll Cardiol , vol.63 , pp. 2304-2322
    • Anderson, J.L.1    Heidenreich, P.A.2    Barnett, P.G.3
  • 21
    • 84921404014 scopus 로고    scopus 로고
    • Angioplasty of femoral-popliteal arteries with drug-coated balloons: 5-year follow-up of the THUNDER trial
    • 21 Tepe, G., Schnorr, B., Albrecht, T., et al. Angioplasty of femoral-popliteal arteries with drug-coated balloons: 5-year follow-up of the THUNDER trial. J Am Coll Cardiol Intv 8 (2015), 102–108.
    • (2015) J Am Coll Cardiol Intv , vol.8 , pp. 102-108
    • Tepe, G.1    Schnorr, B.2    Albrecht, T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.